![]() |
市場調查報告書
商品編碼
2030065
尿道導管市場-全球產業規模、佔有率、趨勢、機會和預測:按產品、應用、類型、最終用戶、地區和競爭對手分類,2021-2031年Urinary Catheters Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Application, By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球導尿管市場預計將從 2025 年的 59.6 億美元成長到 2031 年的 83.7 億美元,複合年成長率為 5.82%。
這些植入膀胱以輔助尿液排放的醫療設備主要用於治療閉尿症、尿失禁或手術全期膀胱管理的患者。市場成長的主要促進因素是泌尿系統疾病發生率的上升,尤其是在老年人口不斷成長的背景下,以及需要臨時或長期使用導尿管的手術數量的激增。為了佐證這一廣泛需求,國際尿失禁協會(ICS-EUS)於2025年9月發布的執行摘要指出,63%的20歲以上美國女性患有尿失禁,這意味著約有7950萬人需要可靠的膀胱護理方案。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 59.6億美元 |
| 市場規模:2031年 | 83.7億美元 |
| 複合年成長率:2026-2031年 | 5.82% |
| 成長最快的細分市場 | 間歇性導尿管 |
| 最大的市場 | 北美洲 |
推動市場進一步成長的主要動力是糖尿病和脊髓損傷等慢性疾病的日益普遍,以及人們對長期照護和居家醫療服務的需求不斷成長。然而,導尿管相關尿道感染這一持續存在的問題仍然是市場成長的主要障礙,給全球醫療保健網路帶來了沉重的臨床和經濟負擔。
全球尿道導管市場的主要驅動力是住院和手術量的增加。隨著急診手術和擇期手術頻率的增加,短期或長期膀胱引流的需求也隨之成長,這直接推動了對導尿管的需求。維茲大學於2025年9月發布的報告(引用《柳葉刀》雜誌的數據)也印證了這項需求,該採血針估計全球每年仍有1.6億例手術需求未得到滿足,凸顯了術前、術中和術後導尿的巨大需求。全球人口老化進一步加劇了這一趨勢,老化使人們更容易患上需要手術的疾病,導致就醫次數增加,從而進一步推高了對導尿管的需求。
同時,導尿管設計和技術的不斷改進正透過緩解主要的臨床挑戰和提升患者舒適度來推動市場成長。產品材料、特殊塗層和人體工學設計的進步,在最大限度地提高使用者舒適度的同時,最大限度地減少了導尿管相關尿道感染等併發症,從而促進了導尿管的廣泛應用。例如,根據科樂普公司於2025年11月發布的2024/25會計年度財報,其採用微孔區技術的Luja間歇導尿管在實現失禁護理領域8%的內部成長方面發揮了關鍵作用。持續創新的成功也體現在領先企業的強勁業績中。例如,BD公司泌尿系統和重症監護部門在其於2025年11月發布的2025會計年度財報中實現了兩位數的成長。
導尿管相關尿道感染(CAUTI)的高發生率是全球導尿管市場擴張的主要障礙。這些併發症對全球醫療基礎設施帶來嚴重的臨床和經濟壓力,直接阻礙了市場發展。 CAUTI通常會導致住院時間延長、額外的診斷程序和昂貴的抗生素治療,從而擠佔了用於採購先進或新型導尿管設備的資金。這種日益成長的經濟壓力最終會影響籌資策略,限制了標準導尿管產品在醫療機構的廣泛應用。
此外,導尿管相關泌尿道感染(CAUTI)的風險引發的安全性擔憂,可能導致醫護人員和患者對使用導尿管猶豫不決,尤其是在存在其他膀胱管理方法的情況下,這可能導致整體需求下降。正如2025年6月在感染控制與流行病學專業人員協會(APIC)會議上強調的那樣,一家醫療機構在2022年至2024年間成功地將CAUTI發生率降低了45%,這表明控制這些問題需要投入大量的資源和精力。這種對感染預防的高度重視凸顯了CAUTI如何對傳統市場成長產生負面影響,促使人們傾向於選擇其他管理方法和防感染設計,而不是簡單地提高標準導尿管的銷售量。
塑造全球導尿管市場的關鍵趨勢之一是家用導尿系統的日益普及。這與醫療模式轉變為門診治療和以患者為中心的醫療保健方式的趨勢不謀而合。這種轉變使得患者即使遠離傳統醫療機構也能自主管理泌尿器官系統需求,從而增加了隱蔽易用型導尿裝置的需求。正如康維特公司2025會計年度(2026年2月)財報所述,該公司失禁護理部門實現了6.6%的內部成長,這主要得益於美國市場銷量的成長以及自我管理產品線的擴展。這一成長凸顯了該產業正在如何發展以滿足消費者對實用家用解決方案的需求,同時減輕臨床醫療系統的負擔。
同時,親水性和抗菌導管塗層的研發正成為一項關鍵趨勢,旨在提高使用者舒適度並應對導管相關尿道感染這一持續存在的挑戰。這些獨特的表面處理對於增強生物相容性和減少細菌黏附至關重要,最終能夠延長導管留置時間並減少醫療併發症。在2025/26會計年度第一季(2026年2月)的中期財務報告中,科樂普宣布其失禁護理產品實現了7%的內部成長。這一強勁的業績主要歸功於持續的設計改進,特別是尖端塗層技術的應用,這些技術為患者提供了更安全、更舒適的體驗,從而促進了這些醫療設備的更廣泛應用和持續使用。
The Global market for urinary catheters is anticipated to expand from USD 5.96 billion in 2025 to USD 8.37 billion by 2031, progressing at a compound annual growth rate of 5.82%. These medical instruments, which are introduced into the bladder to aid in urine extraction, are mainly used for individuals dealing with urinary retention, incontinence, or perioperative bladder management needs. Market growth is primarily fueled by a rising frequency of urological ailments, especially within the growing elderly population, along with a surge in surgeries that require either temporary or prolonged catheter use. Highlighting this extensive need, a September 2025 abstract from the International Continence Society (ICS-EUS) noted that urinary incontinence affected 63% of American women aged 20 and older, translating to roughly 79.5 million individuals requiring reliable bladder care options.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 5.96 Billion |
| Market Size 2031 | USD 8.37 Billion |
| CAGR 2026-2031 | 5.82% |
| Fastest Growing Segment | Intermittent Catheters |
| Largest Market | North America |
Additional momentum for the market comes from the escalating rates of chronic diseases like diabetes and spinal cord traumas, coupled with a shifting focus toward long-term care and home-based health services. Nevertheless, the continuous issue of catheter-associated urinary tract infections continues to act as a major barrier to market growth, imposing considerable clinical and financial strains on healthcare networks worldwide.
Market Driver
A primary catalyst for the global urinary catheters market is the rising number of hospitalizations and surgical operations. A higher frequency of both emergency and elective surgeries frequently requires short-term or prolonged bladder drainage, which directly boosts the need for catheter devices. Highlighting this demand, a September 2025 Wits University publication citing The Lancet reported a global unmet surgical need of 160 million procedures annually, pointing to an immense necessity for catheter use before, during, and after surgeries. This momentum is additionally amplified by a globally aging demographic that is more susceptible to medical conditions requiring surgery, thereby increasing hospital visits and the corresponding demand for catheterization.
At the same time, continuous improvements in catheter engineering and technology are stimulating market growth by mitigating key clinical issues and boosting patient well-being. Progress in product materials, specialized coatings, and ergonomic designs help minimize complications like catheter-associated urinary tract infections while maximizing user comfort, promoting wider utilization. As an illustration, Coloplast's November 2025 financial report for FY 2024/25 indicated that its Luja intermittent catheter, which utilizes Micro-hole Zone Technology, played a key role in achieving an 8% organic growth in its Continence Care division. The success of such ongoing innovations is reflected in the strong financial outcomes of leading companies, such as BD, whose Urology & Critical Care division posted double-digit growth in its Fiscal 2025 year-end results released in November 2025.
Market Challenge
The prevalence of catheter-associated urinary tract infections (CAUTIs) represents a major obstacle to the expansion of the global urinary catheters market. These complications impose severe clinical and financial pressures on healthcare infrastructures worldwide, acting as a direct bottleneck to market progress. Because CAUTIs often result in prolonged hospitalizations, extra diagnostic procedures, and costly antibiotic therapies, they divert crucial funds away from the procurement of advanced or newer catheter devices. This elevated economic pressure ultimately affects procurement strategies and restricts the widespread integration of standard catheter products into healthcare facilities.
Additionally, safety anxieties linked to the threat of CAUTIs can create reluctance among medical professionals and patients to rely on urinary catheters, especially if alternative methods for bladder management are available, thereby diminishing overall demand. As highlighted during the June 2025 Association of Professionals in Infection Control and Epidemiology (APIC) Conference, a medical facility managed to decrease its CAUTI rates by 45% between 2022 and 2024, demonstrating the immense resources and dedication needed to control these issues. This heavy emphasis on infection prevention highlights how CAUTIs negatively restrict conventional market growth, steering preferences toward alternative management techniques and infection-resistant designs rather than merely boosting standard catheter sales.
Market Trends
A major trend shaping the global urinary catheters market is the rising utilization of home-based catheter systems, which aligns with a wider transition toward outpatient and patient-focused healthcare approaches. This movement gives patients more autonomy to handle their urological needs away from conventional medical facilities, consequently escalating the need for discreet and easy-to-use catheter devices. As noted in ConvaTec's February 2026 earnings report for the 2025 fiscal year, the company's Continence Care division saw a 6.6% organic growth, propelled by higher sales volumes in the United States and an expanded range of self-management products. Such growth underscores how the industry is evolving to meet consumer desires for practical at-home solutions while simultaneously reducing the strain on clinical healthcare systems.
At the same time, the development of hydrophilic and antimicrobial catheter coatings has emerged as a crucial market trend aimed at improving user comfort and tackling the ongoing issue of catheter-associated urinary tract infections. These unique surface treatments are essential for increasing biocompatibility and lowering bacterial attachment, ultimately allowing for longer catheter dwell times and fewer medical complications. In its February 2026 interim financial report for Q1 2025/26, Coloplast revealed a 7% organic increase in Continence Care sales. This positive performance is largely credited to persistent design enhancements, notably cutting-edge coating technologies that offer patients a safer, more comfortable experience, thereby encouraging wider adoption and sustained utilization of these medical devices.
Report Scope
In this report, the Global Urinary Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Urinary Catheters Market .
Global Urinary Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: